Understanding OUR Cytokine-Based Immunotherapy Candidates Our Motivation extends to advancing a robust portfolio of programs directed at growing the horizons of cytokine-based immunotherapy, specifically for cancers where cure selections remain limited. Utilize the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Investigate Our Pipeline https://financefeeds.com/thinkmarkets-wins-newcomer-of-the-year-2024-at-tradingview-awards/